SynthesisFrontiers in pharmacology2026

Infliximab-linked gut microbiome signatures as candidate treatment response biomarkers in pediatric inflammatory bowel disease: a systematic review.

Hala Altaher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.